16 completed, 7 unknown, 6 recruiting, 4 terminated. 10 Not applicable, 4 Phase 3, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 6, Recruiting 2, Terminated 1, Unknown 1 |
| Phase 3 | 4 | Completed 2, Terminated 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Retinal Artery Occlusion: new trials by email Literature Review of Retinal Artery Occlusion trials Research Report on Retinal Artery Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Long-term Clinical Outcomes After Retinal Artery Occlusion retinal artery occlusion - Retinal Artery Occlusion | Recruiting | Chonnam National University Hospital | 15000 | 2026-03-01 | 2026-03-19 | |
| Microneedle Intra-Arterial Injection for Retinal Artery Occlusion Vitrectomy + Direct Intra-Arterial Microneedle Thrombolysis + Standard Care, Standard Clinical Care Only - Central Retinal Artery Occlusion | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 24 | 2025-09-01 | 2025-09-03 |
| Phenotypic and Etiological Characterization of Susac Syndrome Susac Syndrome | Recruiting | Assistance Publique - Hôpitaux de Paris | 180 | 2025-07-01 | 2026-05-07 | |
| Visual Involvement in Giant Cell Arteritis Fluorescein and Indocyanine green Angiography, High-resolution Optical Coherence Tomography, Angio-Optical Coherence Tomography - Giant Cell Arteritis, Visual Impairment | Recruiting | ASST Fatebenefratelli Sacco | 762 | 2024-06-27 | 2024-07-15 | |
| A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO) KUS121 high dose, KUS121 low dose, Sham procedure - Central Retinal Artery Occlusion | Phase 2 | Completed | Kyoto Drug Discovery and Development Co., Ltd. | 17 | 2024-04-16 | 2026-02-18 |
| Effects of HFMH-EMS on Ocular Artery Circulation BOBY, Control - Ocular Surface Disease, Central Retinal Artery Occlusion | Not applicable | Completed | Chung Shan Medical University | 43 | 2023-09-20 | 2025-03-06 |
| Physiotherapy Approach for Susac Syndrome Susac Syndrome | Completed | Rehabilitation Centre Zivot | 1 | 2023-02-13 | 2024-04-05 | |
| Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion Tenecteplase (until trial protocol V04: Alteplase) - Central Retinal Artery Occlusion | Phase 3 | Terminated | University Hospital Tuebingen | 127 | 2022-10-10 | 2026-05-18 |
| Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion intra-arterial thrombolysis, conservative treatments - Central Retinal Artery Occlusion | Not applicable | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 128 | 2022-06-01 | 2022-09-30 |
| High Resolution Optical Coherence Tomography High-resolution optical coherence tomography (High-Res-OCT), Standard spectral domain OCT (SD-OCT) - Retinal Disease, Retinal Detachment | Unknown | Insel Gruppe AG, University Hospital Bern | 550 | 2021-11-30 | 2022-11-29 | |
| TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) Intravenous injection of Tenecteplase and one dose of placebo tablet, One tablet of Acetylsalicylic Acid and one dose of IV placebo - Central Retinal Artery Occlusion | Phase 3 | Completed | Oslo University Hospital | 81 | 2020-10-30 | 2025-09-29 |
| Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph Software assisted imaging diagnosis - Diabetic Retinopathy, Retinal Vein Occlusion | Completed | Visionary Intelligence Ltd. | 748 | 2020-08-10 | 2021-12-30 | |
| Changes of Visual Field Defects After IAT for CRAO selective intra-arterial thrombolysis - Central Retinal Artery Occlusion, Visual Field | Completed | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 27 | 2020-07-01 | 2023-02-22 | |
| New Non-invasive Modalities for Assessing Retinal Structure and Function LSFG-NAVI - Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion | Not applicable | Recruiting | Randy Kardon | 500 | 2019-05-06 | 2026-09-08 |
| A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion Alteplase, acetylsalicylic acid, Placebo Oral Tablet - Central Retinal Artery Occlusion | Phase 3 | Completed | Nantes University Hospital | 70 | 2018-06-08 | 2024-01-24 |
| Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO) Additional MRI sequences - Retinal Artery Occlusion, Magnetic Resonance Imaging | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 63 | 2017-12-13 | 2026-01-05 | |
| The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo Hypoxia, Regadenoson - Retinal Artery Occlusion | Phase 2 | Unknown | University of Aarhus | 20 | 2017-03-22 | 2017-03-28 |
| Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion Optical coherence tomography angiography - Retinal Artery Occlusion | Completed | Semmelweis University | 42 | 2017-01-09 | 2021-10-06 | |
| Study of Arterial Recanalization of the Central Retinal Artery Occlusions Central Retinal Artery Occlusion | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 80 | 2016-12-23 | 2022-04-14 |
Showing 20 of 34. Sign in to see all of them.
Retinal Vein Occlusion (9) · Diabetic Retinopathy (5) · Macular Degeneration (4) · Susac Syndrome (4) · Optic Neuropathy, Ischemic (3) · Blindness (2) · Central Serous Chorioretinopathy (2) · Glaucoma (2) · Hypertensive Retinopathy (2) · Macular Edema (2) · Ocular Hypertension (2) · Optic Nerve Diseases (2) · Papilledema (2) · Retinal Detachment (2)
Arterial Occlusive Diseases (34) · Cardiovascular Diseases (34) · Eye Diseases (34) · Vascular Diseases (34) · Retinal Diseases (32) · Nervous System Diseases (13) · Pathological Conditions, Signs and Symptoms (13) · Embolism and Thrombosis (10) · Signs and Symptoms (10) · Neurologic Manifestations (9) · Thrombosis (9) · Venous Thrombosis (9) · Cranial Nerve Diseases (7) · Retinal Degeneration (7) · Central Nervous System Diseases (6)
Aspirin (3) · Tenecteplase (2) · Conservative Treatment (1) · Diffusion Tensor Imaging (1) · KUS121 (1) · Oxygen (1) · Standard of Care (1) · Tissue Plasminogen Activator (1) · Vitrectomy (1) · regadenoson (1)
Assistance Publique - Hôpitaux de Paris (2) · Fondation Ophtalmologique Adolphe de Rothschild (2) · University of Aarhus (2) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (2) · ASST Fatebenefratelli Sacco (1) · Asociación para Evitar la Ceguera en México (1) · Centre Hospitalier Intercommunal Creteil (1) · Charite University, Berlin, Germany (1) · Chonnam National University Hospital (1) · Chung Shan Medical University (1) · Insel Gruppe AG, University Hospital Bern (1) · Jay C. Buckey Jr. (1) · Kyoto Drug Discovery and Development Co., Ltd. (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Nantes University Hospital (1)
France (6) · United States (5) · China (4) · Germany (3) · Austria (2) · Denmark (2) · Switzerland (2) · Belgium (1) · Bosnia and Herzegovina (1) · Canada (1) · Finland (1) · Hungary (1) · Italy (1) · Lithuania (1) · Mexico (1)
Ping Fei, MD#PhD (2) · Alessandro Invernizzi, Prof. (1) · Chris Hudson, OD, PhD (1) · Christoph Leisser, MD (1) · Daniel M Schwartz, M.D. (1) · Florian Gekeler, MD, Prof (1) · Janet Pope, MD (1) · Jay Buckey (1) · Julia A Haller, MD (1) · Karim Sacre, MD, PHD (1) · Kunihiro Musashi, MD., Ph.D. (1) · L. J Katz, MD (1) · Lisa A Hark, PhD (1)
PMID 39614619, PMID 21467183, PMID 23049087, PMID 26349479, PMID 28673747, PMID 30770354, PMID 31828475, PMID 33773011, PMID 34014814, PMID 34382290, PMID 38212607, PMID 38235955, PMID 39305913, PMID 39593673, PMID 39686647, PMID 41109232, PMID 41604638
2018 (1)